The illegal toxic drug supply and overdose crisis is having tragic impacts on communities throughout Canada. Our family, friends and neighbours have been impacted by this tragic public health crisis. Canada's approach is focused on providing access to a full continuum of health care services and leveraging tools at our disposal to save lives, connect […]

Addition expands national network of compounding pharmacies in the west and northwest, including California Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies, today announced its acquisition of Washington-based Cascade Specialty Pharmacy. Cascade Specialty Pharmacy brings a robust legacy of excellence in ENT and Animal Health compounding to Revelation Pharma's growing portfolio.

Hernest is delighted to introduce its exclusive new collection, a testament to the brand's distinctive approach to modern furniture design. This carefully curated series features five exceptional pieces, each thoughtfully crafted to elevate the aesthetics and functionality of any space, from cozy living rooms to elegant dining areas. With a focus on timeless design and

AvaWatz Company (“AvaWatz”), a trusted partner of U.S. Defense and Homeland Security and a leader in AI-driven autonomous systems is excited to announce the launch of a new equity crowdfunding campaign on Wefunder – https://wefunder.com/avawatz. Building on its mission-critical technologies and commercial successes, AvaWatz invites early supporters and new investors to join this groundbreaking opportunity

Wolff's Successes Scaling Global Companies will Further Q4's Strategic Growth as the Company Extends its Leadership in IR Ops Software – Helping More Businesses Elevate Investor Relations with AI Q4 Inc., the leading provider of IR Ops software, today announced the appointment of Jake Wolff as chief revenue officer (CRO). In his role, Wolff will

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Equativ, a global independent adtech company, today announced major upgrades to its all-in-one curation platform, Equativ Buyer Connect (EBC), now renamed Maestro by Equativ, that centralizes programmatic campaign management and provides ad buyers with direct access to high-quality, scaled supply. Since launching its curation platform four years

Novel breakthrough: first molecule to modulate the fundamental mechanism ofT cell activation underlying autoimmune pathology Statistically significant improvements in T cell and psoriasis-related biomarkers in line with PASI improvements in Phase 2a in patients with psoriasis Phase 2a confirms well-tolerated safety profile, with no infections or discontinuations Artax Biopharma, Inc., a clinical-stage biotechnologycompany focused on

Declares interim dividend of 20 per share Persistent Systems (BSE: 533179) (NSE: PERSISTENT)today announced the Company's audited financial results for the quarter ended December 31, 2024, as approved by the Board of Directors. https://mma.prnewswire.com/media/1022385/Persistent_Systems_Logo.jpg Consolidated Financial Highlights for the Quarter ended December 31, 2024 Q3FY25 Margin% QoQ YoYRevenue (USD Million) 360.2 4.3% 19.9%Revenue (INR Million)

REI Systems, a leader in delivering innovative and reliable technology solutions to the federal government for over 35 years, today announced that the company was awarded a position on the Navy SeaPort Next Generation (NxG) contract vehicle. This achievement underscores REI Systems' commitment to helping our customers solve complex challenges, make data-driven decisions, streamline processes

First patient enrolled in NIH/NHLBI-sponsored Phase 1 Study of fostamatinib, Rigel's oral SYK inhibitor Rigel Pharmaceuticals, Inc.(Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of escalating doses of fostamatinib, the company's oral spleen tyrosine kinase (SYK) inhibitor, in patients with sickle cell disease